Promoting Excellence in Education, Research,
and Patient Care in the Rapidly Evolving
Management of Gastrointestinal Cancer
International Society of
Gastrointestinal Oncology
isgioEstablished 2003
2008 Gastrointestinal Oncology Conference Review

2008 Gastrointestinal Oncology Conference
September 25-27, 2008

Please click on abstract title to review abstract PDF file (opens in a new window).

Session I: Esophageal Cancer
Epidemiology and Biology of Esophageal Cancer
Steven R. DeMeester

Principles of Modern Radiation Techniques for Esophageal and Gastroesophageal Junction Cancers
Gary Y. Yang

Proffered Papers

LIP-rMDVA+VRL Composed of Liposomal cDNA Encoding Recombinant Multimodular Proteins rMDVA Comprising Disintegrin/Cysteine-Rich Disulfide Bond 2RGD, and C-Terminal Domain (Ammodystatin), Metalloprotease-Domain (Ammodylysin), and Dimeric Disintegrin/MLD-VGD Domain (VADD) Isolated From Vipera Ammodytes, Exerted Synergistic Action with Vinorelbine Tartrate Against Metastatic Esophageal Squamous Cell Cancer, Circumventing Chemotherapy-Mediated Systemic Toxicity
John Giannios

Safety of Minimally Invasive Esophagectomy in Malignancy
Amit Khithani

Predictors for the Development of Mucositis in Patients with Esophageal Carcinoma Receiving Concurrent Chemotherapy
CJ Devaraju

Session 2: Pancreatic Cancer
Are There Rational Novel Targets for Pancreatic Cancer Therapeutics? Observations from the M.D. Anderson Cancer Center SPORE in Pancreatic Cancer
James Abbruzzese
New Strategies for Success in Pancreatic Adenocarcinoma
Eileen M. O’Reilly
Proffered Papers

Gene Expression Profiling Differentiates Drug-Sensitive and Drug-Resistant Pancreatic Cancer Cell Lines
Thiruvengadam Arumugam

Quality of Life in Patients with Advanced Pancreatic Cancer Receiving Gemcitabine, Capecitabine, and Bevacizumab: Results from a Prospective Multicenter Phase II Trial
Anubba Bharthuar
Anterior Gradient 2 (AGR2) Is Expressed and Secreted During the Development of Pancreatic Cancer and Promotes Cancer Cell Survival
Viji Ramachandran
First-Line Treatment of Metastatic Pancreatic Endocrine Carcinomas with Capecitabine and Temozolomide
Jonathan Strosberg
Session 3: Advanced Colorectal Cancer

New Agents on the Horizon: Positioning Them for Advantage
Leonard Saltz

Curable Metastatic Colorectal Cancer
William Jarnagin

Proffered Papers

Development of, and Initial Data from, a Clinical Pathway for the Treatment of Colon Cancer in the US Oncology Network
Thomas Cartwright

Systemic Chemotherapy with CapOx in Patients with Potentially Resectable Liver Metastases from Colorectal Cancer
Zoran Petrovic

Regulation of Sox9 and Wnt Signaling by Galectin-3 in Human Colon Cancer Cells
Shumei Song

Eradication of Metastatic Colorectal Adenocarcinoma Resistant to Trastuzumab and Cetuximab After Treatment with Immunochemogene SEVINA-IV, a Stealth Nanoparticle Formulation Composed of Clamp PNA Against mRNA of  sGCa1/b1, Anti-MUC1 Chimeric Mab, and Vinorelbine Tartrate
John Giannios
Session 4: Hepatobiliary Cancer
Proffered Papers

ZBP-89 Enhances the Efficacy of Anti-Tumor Agents on Hepatocellular Carcinoma
George G. Chen

Advanced Stage, Not Advanced Age, Influences the Survival of Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma
Jue Wang

Session 5: Emerging Science

The Future of Cancer Genomics: Lessons Learned from the Cancer Genome Atlas Project*
Lynda Chin

Statistical Aspects of Gene Signatures and Molecular Targets
Mithat Gönen

Circulating Tumor Cells: A Promising Biomarker in GI Cancers
Eunice Kwak

Session 6: Adjuvant Colon Cancer

Adjuvant Therapy of Colon Cancer: Lessons Learned and Challenges Ahead*
Norman Wolmark

Proffered Papers

Prognostic Value of Prolactin in Colorectal Carcinoma
Aman Chauhan

Novel Methodology to Evaluate Drugs for Gastrointestinal Malignancies
Helmy M. Guirgis

Insights on CRC Classification Based on Further Analyses of a Large Number of Cases
John Milburn Jessup

The Era of Individualization of Therapy: Focus on K-ras*
Daniel Haller

Session 7: Gastric Cancer

Localized Gastric/Gastroesophageal Cancer – Indications and Results of Chemoradiation
Leonard L. Gunderson

Chemoradiation Is Not Always Needed
Aaron Sasson

Adjuvant Approaches to Gastric Cancer
Al B. Benson III

Proffered Papers

Effect of Imatinib in Patients with Gastrointestinal Stromal Tumor
Arun Sebastian George

Adjuvant Chemotherapy in Completely Resected Gastric Cancer
Zoran Petrovic

Analysis of an Observational Registry of Gastrointestinal Stromal Tumor (GIST) Patients in the USA: reGISTry
Charles Blanke

Session 8: Rectal Cancer

Rectal Cancer - Redefining Clinical Stage Based on Outcomes Data
Leonard Gunderson

Chemoradiation: Are We at a Stand Still?
Christopher Willett

Lymph Node Counts and Survival Rates After Resection for Colon and Rectal Cancer
Sandra Wong

Proffered Papers

Increasing Incidence of Rectal Cancer in Patients Younger Than 40 Years of Age: An Analysis of the SEER Database
Joshua E. Meyer

Submitting to an Oncology Journal: Tricks and Tips*
Daniel Haller

Abstracts Selected for Poster Presentations
(note presenting authors appear in bold)
Esophageal Cancer

Retrospective Study of Esophageal Cancer: A Small-Volume Single-Institution Experience for a 9-Year Period
H. Chin, M. Baumann, N. Katz, M. Reddy, R. Crowell

Pancreatic Cancer

Updated Data Confirm Excellent Activity of Weekly “Metronomic Dosing” of Paclitaxel, Oxaliplatin, Leucovorin, and 5-Fluorouracil (POLF) in Metastatic Pancreatic Adenocarcinoma
Ben M. Chue

Anti-Cancer Effect and Mechanism of Combination of Suberoylanilide Hydroxamic Acid (SAHA) and Bortezomib with Gemcitabine in Pancreatic Cancer Cell Lines
Sang Hyub Lee, Jun Kyu Lee, Ki Young Yang, Jeong Kyun Seo, Joo Kyung Park, Jin-Hyeok Hwang, Ji Kon Ryu, Yong-Tae Kim, Yong Bum Yoon

Proton Radiotherapy for Pancreatic Cancer: A Dosimetric Comparison with Photons
Wenyin Shi, Felicia E. Snead, David Horne, Zuofeng Li, William M. Mendenhall

Adjuvant Chemoradiotherapy for Ampullary Carcinomas
Connie SP Yip, Michael LC Wang

Advanced Colorectal Cancer

Safety of Chronic Low-Dose Capecitabine as Maintenance Therapy in GI Cancers
Rebekah Ryanne Wu, Jun Sun, Rebecca Slack, John Marshall

Hepatobiliary Cancer

Clinical Characteristics of Intrahepatic Biliary Cystic Tumors: Comparison with Intrahepatic Cystic Lesions
Jeong Kyun Seo, Su Hyun Kim, Sang Hyub Lee, Joo Kyung Park, Sang Myung Woo, Ji Bong Jeong, Jin-    Hyeok Hwang, Ji Kon Ryu, Jin-Wook Kim, Sook-Hyang Jeong, Yong-Tae Kim, Yong Bum Yoon, Kuhn Uk Lee, Se Hyung Kim, Min A. Kim

Gastric Cancer

Signet Ring Cell Metastasis with Unknown Primary
Roja Chimakurthi
, Lalit Kalra, Linda Green

Treatment Outcomes of Oxaliplatin, 5-Fluorouracil, and Leucovorin as Salvage Therapy for Patients with Advanced or Metastatic Gastric Cancer: A Retrospective Analysis
Yeul Hong Kim, Hee Yeon Seo, Dae Sik Kim, Yoon Seok Choi, Hwa Jung Sung, Kyong Hwa Park, In Keun Choi, Seok Jin Kim, Sang Cheul Oh, Jae Hong Seo, Chul Won Choi, Byung Soo Kim, Sang Won Shin, Jun Suk Kim